Global Drug Discovery Informatics Market Size, Status and Forecast 2019-2025

2 Global Drug Discovery Informatics Quarterly Market Size Analysis

• 2.1 Drug Discovery Informatics Business Impact Assessment - COVID-19
  • 2.1.1 Global Drug Discovery Informatics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Drug Discovery Informatics Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Drug Discovery Informatics Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Drug Discovery Informatics Headquarters and Area Served
• 3.3 Date of Key Players Enter into Drug Discovery Informatics Market
• 3.4 Key Players Drug Discovery Informatics Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Drug Discovery Informatics Segments, By Type

• 4.1 Introduction
  • 1.4.1 Software
  • 1.4.2 Services
• 4.2 By Type, Global Drug Discovery Informatics Market Size, 2019-2021

5 Impact of Covid-19 on Drug Discovery Informatics Segments, By Application

• 5.1 Overview
  • 5.5.1 Pharmaceutical & Biotechnology Companies
  • 5.5.2 Contract Research Organizations (CROs)
  • 5.5.3 Others
• 5.2 By Application, Global Drug Discovery Informatics Market Size, 2019-2021
  • 5.2.1 By Application, Global Drug Discovery Informatics Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 IBM
  • 7.1.1 IBM Business Overview
  • 7.1.2 IBM Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.1.3 IBM Drug Discovery Informatics Product Introduction
  • 7.1.4 IBM Response to COVID-19 and Related Developments
• 7.2 Infosys
  • 7.2.1 Infosys Business Overview
  • 7.2.2 Infosys Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.2.3 Infosys Drug Discovery Informatics Product Introduction
  • 7.2.4 Infosys Response to COVID-19 and Related Developments
• 7.3 Thermo Fisher Scientific
  • 7.3.1 Thermo Fisher Scientific Business Overview
  • 7.3.2 Thermo Fisher Scientific Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.3.3 Thermo Fisher Scientific Drug Discovery Informatics Product Introduction
  • 7.3.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
• 7.4 Perkinelmer
  • 7.4.1 Perkinelmer Business Overview
  • 7.4.2 Perkinelmer Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.4.3 Perkinelmer Drug Discovery Informatics Product Introduction
  • 7.4.4 Perkinelmer Response to COVID-19 and Related Developments
• 7.5 Schrödinger
  • 7.5.1 Schrödinger Business Overview
  • 7.5.2 Schrödinger Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.5.3 Schrödinger Drug Discovery Informatics Product Introduction
  • 7.5.4 Schrödinger Response to COVID-19 and Related Developments
• 7.6 Dassault Systèmes
  • 7.6.1 Dassault Systèmes Business Overview
  • 7.6.2 Dassault Systèmes Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.6.3 Dassault Systèmes Drug Discovery Informatics Product Introduction
  • 7.6.4 Dassault Systèmes Response to COVID-19 and Related Developments
• 7.7 Charles River Laboratories
  • 7.7.1 Charles River Laboratories Business Overview
  • 7.7.2 Charles River Laboratories Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.7.3 Charles River Laboratories Drug Discovery Informatics Product Introduction
  • 7.7.4 Charles River Laboratories Response to COVID-19 and Related Developments
• 7.8 Selvita
  • 7.8.1 Selvita Business Overview
  • 7.8.2 Selvita Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.8.3 Selvita Drug Discovery Informatics Product Introduction
  • 7.8.4 Selvita Response to COVID-19 and Related Developments
• 7.9 Certara
  • 7.9.1 Certara Business Overview
  • 7.9.2 Certara Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.9.3 Certara Drug Discovery Informatics Product Introduction
  • 7.9.4 Certara Response to COVID-19 and Related Developments
• 7.10 GVK Biosciences
  • 7.10.1 GVK Biosciences Business Overview
  • 7.10.2 GVK Biosciences Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.10.3 GVK Biosciences Drug Discovery Informatics Product Introduction
  • 7.10.4 GVK Biosciences Response to COVID-19 and Related Developments
• 7.11 Collaborative Drug Discovery
  • 7.11.1 Collaborative Drug Discovery Business Overview
  • 7.11.2 Collaborative Drug Discovery Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.11.3 Collaborative Drug Discovery Drug Discovery Informatics Product Introduction
  • 7.11.4 Collaborative Drug Discovery Response to COVID-19 and Related Developments
• 7.12 Openeye Scientific Software
  • 7.12.1 Openeye Scientific Software Business Overview
  • 7.12.2 Openeye Scientific Software Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.12.3 Openeye Scientific Software Drug Discovery Informatics Product Introduction
  • 7.12.4 Openeye Scientific Software Response to COVID-19 and Related Developments
• 7.13 IO Informatics
  • 7.13.1 IO Informatics Business Overview
  • 7.13.2 IO Informatics Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.13.3 IO Informatics Drug Discovery Informatics Product Introduction
  • 7.13.4 IO Informatics Response to COVID-19 and Related Developments
• 7.14 Novo Informatics
  • 7.14.1 Novo Informatics Business Overview
  • 7.14.2 Novo Informatics Drug Discovery Informatics Quarterly Revenue, 2020
  • 7.14.3 Novo Informatics Drug Discovery Informatics Product Introduction
  • 7.14.4 Novo Informatics Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US